BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 34721287)

  • 1. The Value of Anti-Müllerian Hormone in the Prediction of Spontaneous Pregnancy: A Systematic Review and Meta-Analysis.
    Lin C; Jing M; Zhu W; Tu X; Chen Q; Wang X; Zheng Y; Zhang R
    Front Endocrinol (Lausanne); 2021; 12():695157. PubMed ID: 34721287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using serum anti-Müllerian hormone levels to predict the chance of live birth after spontaneous or assisted conception: a systematic review and meta-analysis.
    Peigné M; Bernard V; Dijols L; Creux H; Robin G; Hocké C; Grynberg M; Dewailly D; Sonigo C
    Hum Reprod; 2023 Sep; 38(9):1789-1806. PubMed ID: 37475164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of the lower serum anti-Müllerian hormone threshold for ovarian stimulation prior to in-vitro fertilization using the Elecsys® AMH assay: a prospective observational study.
    Grynnerup AG; Løssl K; Pilsgaard F; Lunding SA; Storgaard M; Bogstad JW; Prætorius L; Zedeler A; Bungum L; Nyboe Andersen A; Pinborg A
    Reprod Biol Endocrinol; 2019 Jan; 17(1):11. PubMed ID: 30634990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of antral follicle count and serum anti-Müllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment?
    Lee Y; Kim TH; Park JK; Eum JH; Lee HJ; Kim J; Lyu SW; Kim YS; Lee WS; Yoon TK
    Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():151-155. PubMed ID: 29306180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-müllerian hormone as a predictor for live birth among women undergoing IVF/ICSI in different age groups: an update of systematic review and meta-analysis.
    Li NJ; Yao QY; Yuan XQ; Huang Y; Li YF
    Arch Gynecol Obstet; 2023 Jul; 308(1):43-61. PubMed ID: 35907969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis.
    Tal R; Tal O; Seifer BJ; Seifer DB
    Fertil Steril; 2015 Jan; 103(1):119-30.e3. PubMed ID: 25450298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal serum concentration of anti-Müllerian hormone is a better predictor than basal follicle stimulating hormone of successful blastocysts development during IVF treatment.
    Sadruddin S; Barnett B; Ku L; Havemann D; Mucowski S; Herrington R; Burggren W
    PLoS One; 2020; 15(10):e0239779. PubMed ID: 33044971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does an association exist between menstrual cycle length within the normal range and ovarian reserve biomarkers during the reproductive years? A systematic review and meta-analysis.
    Younis JS; Iskander R; Fauser BCJM; Izhaki I
    Hum Reprod Update; 2020 Nov; 26(6):904-928. PubMed ID: 32514566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormone.
    Hamdine O; Eijkemans MJ; Lentjes EW; Torrance HL; Macklon NS; Fauser BC; Broekmans FJ
    Hum Reprod; 2015 Jan; 30(1):170-8. PubMed ID: 25355590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian response prediction in controlled ovarian stimulation for IVF using anti-Müllerian hormone in Chinese women: A retrospective cohort study.
    Zheng H; Chen S; Du H; Ling J; Wu Y; Liu H; Liu J
    Medicine (Baltimore); 2017 Mar; 96(13):e6495. PubMed ID: 28353597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach.
    Broer SL; van Disseldorp J; Broeze KA; Dolleman M; Opmeer BC; Bossuyt P; Eijkemans MJ; Mol BW; Broekmans FJ;
    Hum Reprod Update; 2013; 19(1):26-36. PubMed ID: 23188168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of Anti-Müllerian hormone in low and extremely low ovarian reserve in relation to live birth after in vitro fertilization.
    Reijnders IF; Nelen WL; IntHout J; van Herwaarden AE; Braat DD; Fleischer K
    Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():45-50. PubMed ID: 26967346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive accuracy of anti-Müllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature.
    Iliodromiti S; Kelsey TW; Wu O; Anderson RA; Nelson SM
    Hum Reprod Update; 2014; 20(4):560-70. PubMed ID: 24532220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of serum anti-Mullerian hormone as a biomarker of early ovarian aging in young women undergoing IVF/ICSI cycle.
    Lin PY; Huang FJ; Kung FT; Chiang HJ; Lin YJ; Lin YC; Lan KC
    Int J Clin Exp Pathol; 2014; 7(9):6245-53. PubMed ID: 25337276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does anti-Müllerian hormone predict menopause in the general population? Results of a prospective ongoing cohort study.
    Depmann M; Eijkemans MJ; Broer SL; Scheffer GJ; van Rooij IA; Laven JS; Broekmans FJ
    Hum Reprod; 2016 Jul; 31(7):1579-87. PubMed ID: 27179263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive values of anti-müllerian hormone, antral follicle count and ovarian response prediction index (ORPI) for assisted reproductive technology outcomes.
    Ashrafi M; Hemat M; Arabipoor A; Salman Yazdi R; Bahman-Abadi A; Cheraghi R
    J Obstet Gynaecol; 2017 Jan; 37(1):82-88. PubMed ID: 27976974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles.
    Mutlu MF; Erdem M; Erdem A; Yildiz S; Mutlu I; Arisoy O; Oktem M
    J Assist Reprod Genet; 2013 Jun; 30(5):657-65. PubMed ID: 23508679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications.
    Broer SL; Broekmans FJ; Laven JS; Fauser BC
    Hum Reprod Update; 2014; 20(5):688-701. PubMed ID: 24821925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of anti-Müllerian hormone in predicting pregnant outcomes of polycystic ovary syndrome patients undergone assisted reproductive technology].
    Li Y; Tan JQ; Mai ZY; Yang DZ
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jan; 53(1):23-30. PubMed ID: 29374882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.